These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24317175)

  • 1. Genome-wide association studies meet chemoprevention.
    Thompson PA
    J Natl Cancer Inst; 2013 Dec; 105(24):1847-8. PubMed ID: 24317175
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.
    Nan H; Morikawa T; Suuriniemi M; Imamura Y; Werner L; Kuchiba A; Yamauchi M; Hunter DJ; Kraft P; Giovannucci EL; Fuchs CS; Ogino S; Freedman ML; Chan AT
    J Natl Cancer Inst; 2013 Dec; 105(24):1852-61. PubMed ID: 24317174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and Delayed Chemoprevention of Colorectal Cancer.
    Giovannucci E
    Clin Chem; 2018 Nov; 64(11):1668-1669. PubMed ID: 30068694
    [No Abstract]   [Full Text] [Related]  

  • 4. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
    Tuccori M; Filion KB; Azoulay L
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
    [No Abstract]   [Full Text] [Related]  

  • 5. New data on aspirin and colorectal cancer brings calls for new guidelines, more research.
    McNeil C
    J Natl Cancer Inst; 2012 Feb; 104(3):172-7. PubMed ID: 22271767
    [No Abstract]   [Full Text] [Related]  

  • 6. Response.
    Ait Ouakrim D; Dashti SG; Win AK
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711871
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
    Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention.
    Hubner RA; Muir KR; Liu JF; Logan RF; Grainge MJ; Houlston RS;
    Clin Cancer Res; 2008 Apr; 14(8):2303-9. PubMed ID: 18413818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of aspirin associated with SNP.
    Cancer Discov; 2014 Mar; 4(3):OF5. PubMed ID: 24596220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer.
    Squires H; Tappenden P; Cooper K; Carroll C; Logan R; Hind D
    Clin Ther; 2011 Sep; 33(9):1289-305. PubMed ID: 21840057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
    J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colon carcinoma--a preventable disease? Strategies for chemoprevention].
    Seufferlein T; Adler G
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():79-83. PubMed ID: 12467019
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoprevention of colorectal cancer.
    Biasco G; Di Marco M; Pantaleo MA
    Int J Biol Markers; 2003; 18(1):75-7. PubMed ID: 12699069
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoprevention of colorectal cancer for broad clinical use in the future].
    Mutoh M; Ishikawa H; Wakabayashi K
    Gan To Kagaku Ryoho; 2015 May; 42(5):534-7. PubMed ID: 25981646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a cancer-chemopreventive diet.
    Drew DA; Chan AT
    Nat Biomed Eng; 2018 Jan; 2(1):6-7. PubMed ID: 31015662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and NSAID chemoprevention, gene-environment interactions, and risk of colorectal cancer.
    Wender RC
    JAMA; 2015 Mar; 313(11):1111-2. PubMed ID: 25781439
    [No Abstract]   [Full Text] [Related]  

  • 18. Stats on statins: anything but static.
    McLaughlin J
    J Natl Cancer Inst; 2006 Jan; 98(1):4-5. PubMed ID: 16391362
    [No Abstract]   [Full Text] [Related]  

  • 19. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
    Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
    PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aspirin a day: the allure (and distraction) of chemoprevention.
    Levy IG; Pim CP
    J Natl Cancer Inst; 2012 Dec; 104(23):1782-4. PubMed ID: 23197493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.